AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Opglim M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Opsiscare Lifesciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Opglim M 1mg/500mg Tablet SR

Diabetic patients (adults) may use the extended-release Opglim M 1mg/500mg tablet, a dual-action anti-diabetic medication, to manage type 2 diabetes mellitus. This medication regulates blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial, even with well-controlled blood sugar, as discontinuation without medical guidance can elevate glucose levels, potentially causing kidney issues, vision loss, neuropathy, and limb complications. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as recommended by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by symptoms like sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods or juice) is essential. Alcohol consumption should be limited due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should consult their physician before use. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose checks and potential blood tests for blood cell counts and liver function are recommended by your doctor.

Primary Ingredients of Opglim M 1mg/500mg Tablet SR

No text provided. Please provide the text you want me to rephrase.

Uses of Opglim M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Opglim M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Opglim M 1mg/500mg Sustained-Release Tablet should be administered with a meal.

Common Side effects of Opglim M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Opglim M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Opglim M 1mg/500mg Extended-Release Tablet with food.

How Opglim M 1mg/500mg Tablet SR works:

Opglim M SR tablets (1mg glimepiride/500mg metformin) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Opglim M 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Opglim M 1mg/500mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Opglim M 1mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Opglim M 1mg/500mg Tablet SR, as dosage modification may be necessary. Consult a physician before use. Opglim M 1mg/500mg Tablet SR is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Opglim M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiating treatment with a low dose of Opglim M 1mg/500mg SR tablets is typical; however, it's contraindicated in cases of severe liver disease.

What if you forget to take Opglim M 1mg/500mg Tablet SR :

Should you forget to take your Opglim M 1mg/500mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Opglim M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Opglim M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Opglim M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Opglim M 1mg/500mg Tablet SR and seek immediate medical attention.
Opglim M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for treating type 1 diabetes.
Opglim M 1mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Opglim M 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some research.
Opilim M 1mg/500mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Opglim M 1mg/500mg SR tablets with alcohol is unsafe. Alcohol can further reduce blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Opglim M 1mg/500mg Tablet...
78
MRP 95
17% off